← All organizations
Hormozgan University of Medical Sciences
Academic/HospitalWebsite ↗
Also known as: Aida Najafian | Hamidreza Mahboobi | Hormozgan University of Medical Science (HUMS) | Hormozgan University of Medical Sciences | Hormozgan University of Medical Sciences (HUMS) | Hormzgan University of Medical Sciences (HUMS)
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Feb 1, 2021
Timeline
1980s
- Jun 1, 1983
Hormozgan University of Medical Sciences— Founded
Drugs by trial phase (26 distinct, 22 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Cardiac Complexes, Premature
- Cerebral Palsy
- Enuresis
- Femoral Fractures
- Fetal Death
- Fractures, Bone
- Hemorrhage
- Hyperbilirubinemia
- Hyperbilirubinemia, Neonatal
- Muscle Spasticity
- Neonatal Sepsis
- Nocturnal Enuresis
- Otitis
- Otitis Media
- Otitis Media with Effusion
- Pneumonia
- Postpartum Hemorrhage
- Pre-Eclampsia
- Pregnancy, Ectopic
- Premature Rupture of Fetal Membranes
- Rupture
- Sepsis
- Toxemia
- Urinary Incontinence
Recent trials (50)
- NCT06677684Sponsor investigatorN/AFeb 1, 2021
- NCT06677684Lead sponsorN/AFeb 1, 2021
- NCT06665503Lead sponsorN/ASep 1, 2020
- NCT06665503OfficialN/ASep 1, 2020
- NCT06665503Sponsor investigatorN/ASep 1, 2020
- NCT03795974CollaboratorPhase 2Jul 23, 2017
- NCT03795974Study directorPhase 2Jul 23, 2017
- NCT02954926Lead sponsorPhase 3Nov 1, 2015
- NCT02954926Reponsible party - principal investigatorPhase 3Nov 1, 2015
- NCT02658760Lead sponsorPhase 3Jun 1, 2015
- NCT02658760Sponsor investigatorPhase 3Jun 1, 2015
- NCT02658760Overall official - principal investigatorPhase 3Jun 1, 2015
- NCT02936895Lead sponsorPhase 4Jan 1, 2015
- NCT02936895Reponsible party - principal investigatorPhase 4Jan 1, 2015
- NCT02541760Lead sponsorPhase 3Apr 1, 2014
Details
- Founded
- Bandar Abbas, IR Jun 1, 1983
- Last known activity
- Feb 1, 2021